Anti-KRT1 monoclonal antibody, clone 90

Antibody Isotype

IgG1

Clone

90

Species Reactivity

Mouse; Rat; Human

Immunogen

Callus cytokeratins isolated from fresh human skin tissue

Conjugate

Application Notes

Flow Cyt: 1/20; ICC/IF: 1μg/ml.

Alternative Names

KRT1; keratin 1; EHK1,epidermolytic hyperkeratosis 1; keratin, type II cytoskeletal 1; KRT1A; 67 kDa cytokeratin; CK 1; CK1; Cytokeratin 1; Cytokeratin 2; Cytokeratin1; EHK 1; EHK1; Hair alpha protein; K1; Keratin 1; Keratin 1 epidermolytic hyperkeratosis

Entrez Gene ID

UniProt ID

Antigen Description

This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where its believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. Mutants of p53 that frequently occur in a number of different human cancers fail to bind the consensus DNA binding site, and hence cause the loss of tumor suppressor activity. Alterations of this gene occur not only as somatic mutations in human malignancies, but also as germline mutations in some cancer-prone families with Li-Fraumeni syndrome. Multiple p53 variants due to alternative promoters and multiple alternative splicing have been found. These variants encode distinct isoforms, which can regulate p53 transcriptional activity.

Pathway

Regulation of Wnt-mediated beta catenin signaling and target gene transcription, organism-specific biosystem;